Stem Cell Cancer


Cancer When transplanted into an animal host, stem cells (CSCs), a tiny fraction of cells within tumours, are capable of self-renewal, differentiation, and tumorigenicity. To recognise and enrich CSCs, a range of cell surface markers, including CD44, CD24, and CD133, are frequently utilised.

Some cancers, such as leukaemia, lymphoma, and myeloma, can be treated by bone marrow or stem cell transplantation. High dose chemotherapy and occasionally radiotherapy are used to treat them. They may also be referred to as intense treatment, stem cell rescue, or bone marrow rescue. At 20 years after transplantation, the study cohort's estimated survival rate was 80.4% (95% CI, 78.1% to 82.6%). Age at transplantation was inversely linked with survival after five years.


 


  • Chemotherapy
  • Radiotherapy

Related Conference of Stem Cell Cancer

September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

44th Euro Congress on Cancer Science & Therapy

Paris, France
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK

Stem Cell Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in